Dallas, Texas (PRWEB) November 15, 2013
Global hospital cardiac patient monitoring devices market at $3.8 billion in 2012 is forecast to reach at $5.3 billion by 2019 at a growth rate of 5.5% during the analysis period. Growth continues as market penetration into all areas of the hospital expands. The installed base continues to grow as replacement of units is stretched to 12 years and beyond.
The study has 230 pages, 102 tables and figures. Whereas cardiac monitor units were initially used in newly created critical care units, now many patients with primary disease conditions other than cardiac disease also have complications that affect the heart and therefor need monitoring in other parts of the hospital.
The hospital cardiac patient monitoring industry (http://www.reportsnreports.com/reports/270681-hospital-patient-multi-parameter-monitors-market-shares-strategies-and-forecasts-worldwide-2013-to-2019.html) is evolving rapidly and is becoming increasingly competitive as more parameters are monitored and integration with the electronic patient record occurs. This is the basis on which vendor share shifts, with Philips gaining share in recent years. Companies with substantial resources are poised to enter the market, probably through acquisition. Vendors are poised to face increased competition even as market consolidation occurs.
Shortness of breath is a common symptom of cardiac disease. It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a symptom. Hospital cardiac patient monitoring can detect arrhythmias and get people to treatment faster before it is too late to correct heart failure.
Early detection of a problem in the hospital and consequent treatment is essential. Hospital cardiac patient monitoring technology is a vital aid in providing that treatment. Hospitals and clinicians have increased access to devices in every department of the hospital and during transport as insurers realize the value of detecting and treating cardiac symptoms as they occur, rather than waiting until the patient condition has deteriorated.
Cardiac patient monitoring is evolving as systems become smaller and offer more functionality. Cardiac patient monitoring market driving forces still relate to reimbursement by CMS and private insurance carriers in the US and by nationalized systems in other places. The principal competitive factors that impact the success of cardiac monitoring solutions include the parameters discussed in the market research study.
Purchase report at http://www.reportsnreports.com/purchase.aspx?name=270681.
According to the Hospital Patient Multi -Parameter Monitors market research study, "Hospital cardiac patient monitoring technology companies are struggling to achieve a focus on health delivery and well-being initiatives. Vendors strive for a balanced portfolio of businesses that can attain global leadership positions. Vendors seek to deliver performance above benchmark levels. Challenges are influencing hospital cardiac patient monitoring business activities."
When chronic disease conditions are treated early on when there is an early change in patient condition an early intervention can make a difference. It is even better to treat patients in a wellness treatment environment before there are indications of chronic disease, before symptoms develop, by addressing lifestyle issues early on.
Request Sample for this Report at http://www.reportsnreports.com/contacts/requestsample.aspx?name=270681.
Hospital Multi-Parameter Patient Monitor Company Profiles: Drager, GE DATEX OHMEDA, Guangdong Biolight Meditech Co., Ltd. (Biolight), Mindray, Mortara, Nihon Kohden, Opto Circuits, OSI, Philips, Schiller.
Browse other reports by WinterGreen Research at http://www.reportsnreports.com/publisher/wintergreen-research/.
ReportsnReports.com is an online market research reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.